GenCaps is a clinical-stage pharmaceutical company developing differentiated oral reformulations
We focus where a targeted change to an existing medicine can make a real difference — especially where treatment is long-term, burden rises with age, or patients depend on others to help manage their medicines.
Starting from the established safety and efficacy of existing small molecules, we design reformulations that address tolerability, adherence, dosing and administration, bringing value to patients and to those who help care for them.
Combining seasoned pharmaceutical, regulatory, medical and commercial expertise to turn promising concepts into protectable, partner-ready opportunities
From Luxembourg, we are well placed to collaborate across neighbouring markets, wider Europe and beyond — and to give each project the structure that suits it. We welcome contact from both individual innovators and companies large and small who would like to explore ideas with us.
Contact